Low Molecular Weight Heparin on the Adenomyosis Patients'IVF-ET Outcome
Status:
Active, not recruiting
Trial end date:
2022-01-31
Target enrollment:
Participant gender:
Summary
In assisted reproductive technology, adenomyosis patients are characterized by lower clinical
pregnancy rate, lower implantation rate and higher abortion rate. The purpose of this study
is to explore whether low molecular weight heparin can reduce the abortion rate of
adenomyosis patients in frozen thawed embryo transfer cycles.